About Roche
Nationality
Austria, Germany
Year of Birth
1975
1997
Genetics at University Salzburg, B.A.
2000
Molecular Biology at New York University, M.S.
2003
Doctorate in Molecular Biology at New York University, Ph.D.
2003–2005
Roche Singapore, Basel, Vienna, and Mannheim, Roche Management Development Program “Perspectives”
2005–2008
Roche Diagnostics Austria, Vienna, Head of Marketing and Sales
2008–2011
Roche Diagnostics Sweden, Stockholm, General Manager
2011–2013
Roche Diagnostics Branford and Madison, Lifecycle Leader Sequencing Solutions
2013–2017
Roche Diagnostics Germany, Mannheim and Roche Holding Germany, Grenzach, General Manager
2018–2019
Roche Rotkreuz, Global Head of Roche Diagnostics Centralized and Point of Care Solutions
2019–2022
Roche Diagnostics Basel, CEO, Member of the Corporate Executive Committee
January 2023–February 2023
Roche Pharma Basel, ad interim CEO
Since March 2023
Roche Group, Chief Executive Officer
–
–
Since 2020
Member of the Innovation Board, Labor Berlin (Charité and Vivantes)
Since 2024
Member of the Foundation Board, IMD Business School
Since 2024
Member of the Foundation Board, Lucerne Festival
Since 2025
Chair of Biopharmaceutical CEOs Roundtable (BCR)
Since 2025
President of International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
Since 2025
Member of the Board of Directors, Chugai Pharmaceutical Co., Ltd
–